Exact Mass: 441.18997620000005
Exact Mass Matches: 441.18997620000005
Found 500 metabolites which its exact mass value is equals to given mass value 441.18997620000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
platencimycin
C24H27NO7 (441.17874320000004)
D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D000890 - Anti-Infective Agents
Imidapril hydrochloride
C20H28ClN3O6 (441.16665380000006)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Nebivolol HCl
C22H26ClF2NO4 (441.1518330000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Nebivolol (R 065824) hydrochloride is an orally active beta receptor blocker and has the high beta(1)-receptor affinity.Nebivolol hydrochloride has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol hydrochloride can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease[1][2].
troglitazone
C24H27NO5S (441.1609852000001)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5234; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5241; ORIGINAL_PRECURSOR_SCAN_NO 5238 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5206; ORIGINAL_PRECURSOR_SCAN_NO 5205 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5244; ORIGINAL_PRECURSOR_SCAN_NO 5241 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5240; ORIGINAL_PRECURSOR_SCAN_NO 5238 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5233; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9800; ORIGINAL_PRECURSOR_SCAN_NO 9795 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9806; ORIGINAL_PRECURSOR_SCAN_NO 9803 Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine?PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.
Mandelonitrile rutinoside
C20H27NO10 (441.1634882000001)
Mandelonitrile rutinoside is found in fruits. Mandelonitrile rutinoside is a constituent of the fruit of purple passion fruit (Passiflora edulis). Constituent of the fruit of purple passion fruit (Passiflora edulis). Mandelonitrile rutinoside is found in fruits.
18-Carboxy-dinor-LTE4
C21H31NO7S (441.18211360000004)
18-carboxy-dinor-LTE4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 18-carboxy-dinor-LTE4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
Vilazodone
Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors. It has been shown to be equally efficacious as other antidepressants with similar gastrointestinal side effects and possibly with reduced sexual side effects and weight gain. Vilazodone is an antidepressant agent that can used as an alternative for patients who cannot tolerate therapy with other antidepressant classes such as selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. Treatment should be titrated towards the target dose, which is 40mg per day. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active?serotonin?reuptake inhibitor (SSRI) and partial?5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders[1][2].
3-N-(2-Fluoroethyl)spiperone
C25H29F2N3O2 (441.22277180000003)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals
Bacmecillinam
C20H31N3O6S (441.19334660000004)
6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]-
C25H23N5O3 (441.18008080000004)
Brivanib alaninate
Cerivastatin lactone
Db-cAMP
C18H28N5O6P (441.17771180000005)
Deflazacort
4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine
troglitazone
C24H27NO5S (441.1609852000001)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine?PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.
4-Hydroxy-5-[[4-[[(2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]methoxy]phenyl]methyl]-3H-1,3-thiazol-2-one
C24H27NO5S (441.1609852000001)
Ergomet
C19H23N3O2.C4H4O4 (441.18997620000005)
Ergometrine maleate is a maleate salt resulting form the reaction of equimolar amounts of maleic acid and ergometrine. It is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced. It has a role as an oxytocic and a diagnostic agent. It contains an ergometrine. An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties. C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D012102 - Reproductive Control Agents > D010120 - Oxytocics
Fleephilone
C24H27NO7 (441.17874320000004)
A organic heterotetracyclic compound isolated from the fermentation broth of Trichoderma harzianum and exhibits anti-HIV activity.
N-Acetoacetyl-N-deacetylcolchicine
C24H27NO7 (441.17874320000004)
14(S)-hydroxyplatencin|14S-hydroxyplatencin|platencin A3
C24H27NO7 (441.17874320000004)
4,5-dihydro-1,4-di(1H-indol-3-yl)furo[3,2:3,4]cyclopent[1,2-b]indol-2-(3alphaH)-one|malasseziacitrin
Floridanine
C21H31NO9 (441.19987160000005)
A pyrrolizine alkaloid that is onetine in which the hydroxy hydrogen has been replaced by an acetyl group. Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids
3-O-(2-butenoyl)-11-O-(3-hydroxybutanoyl)hamayne
C24H27NO7 (441.17874320000004)
(3S,6S)-8-methyl-6-[(phenylcarbonyl)oxy]-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3,5-dimethoxybenzoate|6beta-benzoyloxy-3alpha-(4-hydroxy-3,5-dimethoxybenzoyloxy)tropane
C24H27NO7 (441.17874320000004)
beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-valyl]glucopyranoside
Et glycoside,N-Ac,4,6-dibenzoyl-alpha-D-Pyranose-2-Amino-2,3-dideoxy-ribo-hexopyranose
C24H27NO7 (441.17874320000004)
4-[(beta-D-glucopyranosyl)-(1->3)-(alpha-L-rhamnopyranosyl)]phenylacetonitrile
C20H27NO10 (441.1634882000001)
O-(2-acetamido-2-deoxy-beta-D-galactosyl)-(1->5)-3-deoxy-D-manno-octulosonic acid
Ser His Ala Lys
Ala His Lys Ser
Ala His Asn Thr
Ala His Gln Ser
Ala His Ser Lys
Ala His Ser Gln
Ala His Thr Asn
Ala Lys His Ser
Ala Lys Ser His
Ala Asn His Thr
Ala Asn Thr His
Ala Gln His Ser
Ala Gln Ser His
Ala Ser His Lys
Ala Ser His Gln
Ala Ser Lys His
Ala Ser Gln His
Ala Thr His Asn
Ala Thr Asn His
Asp Gly His Asn
Asp Gly Asn His
Asp His Gly Asn
Asp His Asn Gly
Asp Asn Gly His
Asp Asn His Gly
Asp Asn Pro Pro
C18H27N5O8 (441.18595419999997)
Asp Pro Asn Pro
C18H27N5O8 (441.18595419999997)
Asp Pro Pro Asn
C18H27N5O8 (441.18595419999997)
Gly Asp His Asn
Gly Asp Asn His
Gly His Asp Asn
Gly His Lys Thr
Gly His Asn Asp
Gly His Gln Thr
Gly His Thr Lys
Gly His Thr Gln
Gly Lys His Thr
Gly Lys Thr His
Gly Asn Asp His
Gly Asn His Asp
Gly Gln His Thr
Gly Gln Thr His
Gly Thr His Lys
Gly Thr His Gln
Gly Thr Lys His
Gly Thr Gln His
His Ala Lys Ser
His Ala Asn Thr
His Ala Gln Ser
His Ala Ser Lys
His Ala Ser Gln
His Ala Thr Asn
His Asp Gly Asn
His Asp Asn Gly
His Gly Asp Asn
His Gly Lys Thr
His Gly Asn Asp
His Gly Gln Thr
His Gly Thr Lys
His Gly Thr Gln
His Lys Ala Ser
His Lys Gly Thr
His Lys Ser Ala
His Lys Thr Gly
His Asn Ala Thr
His Asn Asp Gly
His Asn Gly Asp
His Asn Thr Ala
His Gln Ala Ser
His Gln Gly Thr
His Gln Ser Ala
His Gln Thr Gly
His Ser Ala Lys
His Ser Ala Gln
His Ser Lys Ala
His Ser Gln Ala
His Thr Ala Asn
His Thr Gly Lys
His Thr Gly Gln
His Thr Asn Ala
His Thr Gln Gly
10-Hydroxydesmethylnortriptyline glucuronide
C24H27NO7 (441.17874320000004)
Asn Ala His Thr
Asn Ala Thr His
Asn Asp Gly His
Asn Asp His Gly
Asn Asp Pro Pro
C18H27N5O8 (441.18595419999997)
Asn Gly Asp His
Asn Gly His Asp
Asn His Ala Thr
Asn His Asp Gly
Asn His Gly Asp
Asn His Thr Ala
Asn Pro Asp Pro
C18H27N5O8 (441.18595419999997)
Asn Pro Pro Asp
C18H27N5O8 (441.18595419999997)
Asn Thr Ala His
Asn Thr His Ala
Pro Asp Asn Pro
C18H27N5O8 (441.18595419999997)
Pro Asp Pro Asn
C18H27N5O8 (441.18595419999997)
Pro Asn Asp Pro
C18H27N5O8 (441.18595419999997)
Pro Asn Pro Asp
C18H27N5O8 (441.18595419999997)
Pro Pro Asp Asn
C18H27N5O8 (441.18595419999997)
Pro Pro Asn Asp
C18H27N5O8 (441.18595419999997)
Pro Pro Gln Thr
Pro Pro Thr Gln
Pro Gln Pro Thr
Pro Gln Thr Pro
Pro Thr Pro Gln
Pro Thr Gln Pro
Gln Ala His Ser
Gln Ala Ser His
Gln Gly His Thr
Gln Gly Thr His
Gln His Ala Ser
Gln His Gly Thr
Gln His Ser Ala
Gln His Thr Gly
Gln Pro Pro Thr
Gln Pro Thr Pro
Gln Ser Ala His
Gln Ser His Ala
Gln Thr Gly His
Gln Thr His Gly
Gln Thr Pro Pro
Ser Ala His Gln
Ser Ala Gln His
Ser His Ala Gln
Ser His Gln Ala
Ser Gln Ala His
Ser Gln His Ala
Thr Ala His Asn
Thr Ala Asn His
Thr Gly His Gln
Thr Gly Gln His
Thr His Ala Asn
Thr His Gly Gln
Thr His Asn Ala
Thr His Gln Gly
Thr Asn Ala His
Thr Asn His Ala
Thr Pro Pro Gln
Thr Pro Gln Pro
Thr Gln Gly His
Thr Gln His Gly
Thr Gln Pro Pro
Vilazodone
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active?serotonin?reuptake inhibitor (SSRI) and partial?5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders[1][2].
Mandelonitrile rutinoside
C20H27NO10 (441.1634882000001)
18-carboxy-19,20-dinor-leukotriene E4
C21H31NO7S (441.18211360000004)
An icosanoid that is leukotriene E4 in which two methylene groups are removed from the carboxyalkyl chain attached to the non-conjugated double bond.
N,N-ethylenebis[N-(carboxymethyl)glycine], compound with 2,2,2-nitrilotri(ethanol)
Nebivolol hydrochloride
C22H26ClF2NO4 (441.1518330000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Nebivolol (R 065824) hydrochloride is an orally active beta receptor blocker and has the high beta(1)-receptor affinity.Nebivolol hydrochloride has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol hydrochloride can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease[1][2].
3H-Indolium, 2-2-(4,5-dihydro-3,5-diphenyl-1H-pyrazol-1-yl)ethenyl-1,3,3-trimethyl-, chloride
C28H28ClN3 (441.19716380000006)
Nifekalant Hydrochloride
C19H28ClN5O5 (441.17788680000007)
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Brivanib alaninate
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
LY2109761
3-Phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine
C24H27NO5S (441.1609852000001)
6-[2-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one
Quetiapine Fumarate
C23H27N3O4S (441.1722182000001)
Quetiapine hemifumarate is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. Quetiapine hemifumarate is a dopamine receptor antagonist with a pIC50 of 6.33 for human D2 receptor. Quetiapine hemifumarate has moderate to high affinity for the human D2, HT1A, 5-HT2A, 5-HT2C receptor with pKis of 7.25, 5.74, 7.54, 5.55. Antidepressant and anxiolytic effects[1].
Deflazacort
H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents
1,3-Pyrrolidinedicarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-Methoxyphenyl)-, 1-(1,1-diMethylethyl) ester, (2α,3β,4α)-
C24H27NO7 (441.17874320000004)
2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,2-[bis(2-hydroxyethyl)amino]ethanol
(5r)-5-(4-{[(2r)-6-Hydroxy-2,5,7,8-Tetramethyl-3,4-Dihydro-2h-Chromen-2-Yl]methoxy}benzyl)-1,3-Thiazolidine-2,4-Dione
C24H27NO5S (441.1609852000001)
N-(1-Carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine
C23H27N3O6 (441.18997620000005)
Crisnatol mesylate
C24H27NO5S (441.1609852000001)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
6H-Dipyrido[3,2-b:2,3-e][1,4]diazepin-6-one, 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]-
C25H23N5O3 (441.18008080000004)
Platencin A1
C24H27NO7 (441.17874320000004)
A polycyclic cage that is the 9-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.
2-[[2-(2-Cyanophenoxy)-1-oxoethyl]amino]-5,5,7,7-tetramethyl-4,6-dihydrothieno[2,3-c]pyridine-3-carboxylic acid ethyl ester
C23H27N3O4S (441.1722182000001)
2,4-dihydroxy-3-({3-[(2S,3S,4aR,8S,8aR)-3-hydroxy-8-methyl-10-methylidene-7-oxo-1,3,4,7,8,8a-hexahydro-2H-2,4a-ethanonaphthalen-8-yl]propanoyl}amino)benzoic acid
C24H27NO7 (441.17874320000004)
(2r,4s)-2-[(r)-Benzylcarbamoyl-phenylacetyl-methyl]-5,5-dimethyl-thiazolidine-4-carboxylic acid
C23H27N3O4S (441.1722182000001)
Ergonovine maleate
C23H27N3O6 (441.18997620000005)
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D012102 - Reproductive Control Agents > D010120 - Oxytocics
4-Hydroxy-5-[[4-[[(2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]methoxy]phenyl]methyl]-3H-1,3-thiazol-2-one
C24H27NO5S (441.1609852000001)
Cortisol 21-sulfate(1-)
Conjugate base of cortisol 21-sulfate arising from deprotonation of the sulfate OH; major species at pH 7.3.
[(2S,3R,4R,6R)-3-hydroxy-2-methyl-6-(12-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)oxan-4-yl]azanium
C26H25N4O3+ (441.19265599999994)
6-[2-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]vinyl]-4-hydroxy-tetrahydropyran-2-one
platencin A3
C24H27NO7 (441.17874320000004)
A polycyclic cage that is the 4-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.
(3S)-3-(1,3-benzodioxol-5-yl)-1-(3,5-dimethyl-1-piperidinyl)-3-(2-hydroxy-4,6-dimethoxyphenyl)-1-propanone
(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid
C23H27N3O6 (441.18997620000005)
2-[3-[3-[3-(1-Imidazolyl)propyl]-4-oxo-2-quinazolinyl]propyl]isoindole-1,3-dione
C25H23N5O3 (441.18008080000004)
N-(3-methylphenyl)-4-[4-(4-morpholinyl)-3-nitrophenyl]-1-phthalazinamine
C25H23N5O3 (441.18008080000004)
1-[4-[[(5-methyl-7-oxo-4H-isothiazolo[4,3-d]pyrimidin-3-yl)-oxomethyl]amino]phenyl]-3-piperidinecarboxylic acid ethyl ester
C21H23N5O4S (441.14706780000006)
3-nitro-N-[[4-[4-(1-oxopropyl)-1-piperazinyl]anilino]-sulfanylidenemethyl]benzamide
C21H23N5O4S (441.14706780000006)
5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid [2-[2-(3,4-diethoxyphenyl)ethylamino]-2-oxoethyl] ester
C22H27N5O5 (441.20120920000005)
2-[4-(2-chlorobenzyl)piperazin-1-yl]-N-[(1E,2E)-3-(2-nitrophenyl)prop-2-en-1-ylidene]acetohydrazide
C22H24ClN5O3 (441.15675840000006)
N-tert-butyl-2-[[5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(phenylmethyl)acetamide
C23H27N3O4S (441.1722182000001)
3-[[2-[[(2-Methylpropan-2-yl)oxy-oxomethyl]amino]-1-oxoethyl]hydrazo]-3-oxo-2-phenylpropanoic acid (phenylmethyl) ester
C23H27N3O6 (441.18997620000005)
(1R,4S,6R,7R,11Z)-4-hydroxy-4-[(1R)-1-hydroxyethyl]-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C21H31NO9 (441.19987160000005)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
(2S,3S,3aR,9bR)-1-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C24H28ClN3O3 (441.1819088000001)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
(1R,2aR,8bR)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C24H28ClN3O3 (441.1819088000001)
(2R,3R,3aS,9bS)-1-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C24H28ClN3O3 (441.1819088000001)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C20H31N3O6S (441.19334660000004)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H35N3O5S (441.2297300000001)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide
C20H31N3O6S (441.19334660000004)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide
C23H27N3O6 (441.18997620000005)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea
C21H26F3N3O4 (441.1875312000001)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C23H27N3O6 (441.18997620000005)
(1S,2aS,8bS)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C24H28ClN3O3 (441.1819088000001)
(1S,2aR,8bR)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C24H28ClN3O3 (441.1819088000001)
(1R,2aS,8bS)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C24H28ClN3O3 (441.1819088000001)
[(1R)-1-[(2,5-difluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H29F2N3O2 (441.22277180000003)
[(1S)-1-[(2,5-difluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H29F2N3O2 (441.22277180000003)
[(1S)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C23H27N3O4S (441.1722182000001)
[(1R)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C23H27N3O4S (441.1722182000001)
[(1S)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C23H27N3O4S (441.1722182000001)
2,9-Diamino-5,7-bis(trimethylsilyl)benzo[a]pyrimido[2,1,6-cd]pyrrolizine-3,4,8-tricarbonitrile
An organic heterotetracyclic compound consisting of a benzo[a]pyrimido[2,1,6-cd]pyrrolizine ring system having amino substituents at the 2- and 9-positions, trimethylsilyl substituents at the 5- and 7-positions and cyano substituents at the 3-, 4- and 8-postions.
(1R,9S,10S,11S)-12-[(3-chlorophenyl)methyl]-N-ethyl-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H28ClN3O3 (441.1819088000001)
(2R,3R,3aS,9bS)-1-[(2-chlorophenyl)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H28ClN3O3 (441.1819088000001)
(1S,9R,10R,11R)-12-[(3-chlorophenyl)methyl]-N-ethyl-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H28ClN3O3 (441.1819088000001)
(2S,3S,3aR,9bR)-1-[(2-chlorophenyl)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H28ClN3O3 (441.1819088000001)
5-aminopentyl 6-O-alpha-D-glucopyranuronosyl-alpha-D-glucopyranoside
2-Amino-3-[(3-dodecanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
C18H36NO9P (441.2127576000001)
2-Amino-3-[(3-butanoyloxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(2-octanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-hexanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
Platensimycin
C24H27NO7 (441.17874320000004)
A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the oxatetracyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase. D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D000890 - Anti-Infective Agents
1-dodecanoyl-glycero-3-phosphoserine
C18H36NO9P (441.2127576000001)
platencin A2
C24H27NO7 (441.17874320000004)
A polycyclic cage that is the 3-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.
T0467
C24H26F3N5 (441.21401920000005)
T0467 activates parkin mitochondrial translocation in a PINK1-dependent manner in vitro. T0467 do not induce mitochondrial accumulation of PINK1in dopaminergic neurons. T0467 is a potential compound for PINK1-Parkin signaling activation, and can be used for parkinson's disease and related disorders research[1].
3-oxo-n-[(10s)-3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]butanimidic acid
C24H27NO7 (441.17874320000004)
(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s)-2-amino-3-methylbutanoate
2,4-dihydroxy-3-({1-hydroxy-3-[(5s,9s)-9-hydroxy-5-methyl-12-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO7 (441.17874320000004)
2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,6r,8s,9s)-9-hydroxy-5-methyl-12-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO7 (441.17874320000004)
2,4-dihydroxy-3-[(1-hydroxy-3-{11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO7 (441.17874320000004)
6-[(1r,2s)-1-hydroxy-2-{[(2s,3s,4s,5r,6r)-6-(hydroxymethyl)-3,4,5-trimethoxyoxan-2-yl]oxy}propyl]-2-imino-1h-pteridin-4-ol
C18H27N5O8 (441.18595419999997)
(6s)-3,4-bis(4-hydroxyphenyl)-6-(2-methylpropyl)-7-oxa-2-azatricyclo[7.4.0.0²,⁶]trideca-1(13),3,9,11-tetraene-5,8-dione
C27H23NO5 (441.15761480000003)
12-(acetyloxy)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-yl acetate
C24H27NO7 (441.17874320000004)
3,4-bis(4-hydroxyphenyl)-6-(2-methylpropyl)-7-oxa-2-azatricyclo[7.4.0.0²,⁶]trideca-1(13),3,9,11-tetraene-5,8-dione
C27H23NO5 (441.15761480000003)
(10r,11r)-10,14-bis(1h-indol-3-yl)-12-oxa-8-azatetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadeca-1(9),2,4,6,14-pentaen-13-one
(4r,5r,6r,7r)-5-{[(2s,3r,4r,5r,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6,7,8-tetrahydroxy-2-oxooctanoic acid
(1s,13s,15r,18r)-15-{[(3s)-3-hydroxybutanoyl]oxy}-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-yl but-2-enoate
C24H27NO7 (441.17874320000004)
(1r,4r,6r,7r,11z)-4-hydroxy-4-[(1s)-1-hydroxyethyl]-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C21H31NO9 (441.19987160000005)
methyl (1r,5s,6r,9r,10s,13r,19r,21r)-9-[(acetyloxy)methyl]-21-hydroxy-5-methyl-20-oxa-3-azaheptacyclo[11.5.2.1⁶,¹⁰.0¹,⁹.0²,⁶.0¹³,¹⁹.0¹⁶,¹⁹]henicosa-2,16-diene-17-carboxylate
(11r,15r,17r)-5-[(4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione
C24H27NO7 (441.17874320000004)
2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO7 (441.17874320000004)
12-hydroxy-5-methyl-4,6-dioxo-15-(penta-1,3-dien-1-yl)-14-oxa-9-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,7-trien-5-yl 3-hydroxybutanoate
C24H27NO7 (441.17874320000004)
4-hydroxy-4-(1-hydroxyethyl)-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C21H31NO9 (441.19987160000005)
3-({3-[(1s,5s,9s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-1-hydroxypropylidene}amino)-2,4-dihydroxybenzoic acid
C24H27NO7 (441.17874320000004)
3-oxo-n-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}butanimidic acid
C24H27NO7 (441.17874320000004)
6-(1-hydroxy-2-{[6-(hydroxymethyl)-3,4,5-trimethoxyoxan-2-yl]oxy}propyl)-2-imino-1h-pteridin-4-ol
C18H27N5O8 (441.18595419999997)
n-(3-{7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.0³,⁸]heptadeca-3,5,7-trien-11-yl}prop-1-en-1-yl)hepta-2,4-dienimidic acid
3-[(3-{5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}-1-hydroxypropylidene)amino]-2,4-dihydroxybenzoic acid
C24H27NO7 (441.17874320000004)
2-amino-6-hydroxy-7-methyl-5-[(2s)-2-[(1r,3r,4s,5s,8s,9s)-4,8,9-trimethyl-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-3-yl]propanoyl]naphthalene-1,4-dione
C24H27NO7 (441.17874320000004)
(1s,2s,12s,15r)-1,15-dihydroxy-2,7-dimethoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione
C23H27N3O6 (441.18997620000005)
2-(4-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-6-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)acetonitrile
C20H27NO10 (441.1634882000001)
(2s)-2-{[(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-4-phenylbutylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-phenylpropanoic acid
2,4-dihydroxy-3-[(1-hydroxy-3-{9-hydroxy-5-methyl-12-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO7 (441.17874320000004)
(1r,6r,7r)-4-hydroxy-4-(1-hydroxyethyl)-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C21H31NO9 (441.19987160000005)
2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-amino-3-methylbutanoate
(2e,10e)-n-[(2r,3s,4as,8r,8ar)-8-chloro-2,4a-dihydroxy-8a-methyl-5-oxo-2,3,4,8-tetrahydro-1-benzopyran-3-yl]-12-hydroxydodeca-2,10-dienimidic acid
C22H32ClNO6 (441.19180420000004)
9-ethyl-4,5,9-trihydroxy-4-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C21H31NO9 (441.19987160000005)
(12s,13r)-12-hydroxy-5-methyl-4,6-dioxo-15-[(1e,3e)-penta-1,3-dien-1-yl]-14-oxa-9-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,7-trien-5-yl 3-hydroxybutanoate
C24H27NO7 (441.17874320000004)
n-[2,6-dihydroxy-3-(sulfanylcarbonyl)phenyl]-3-[(1s,5s,6r,8s)-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propanimidic acid
C24H27NO5S (441.1609852000001)
10,14-bis(1h-indol-3-yl)-12-oxa-8-azatetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadeca-1(9),2,4,6,14-pentaen-13-one
2,4-dihydroxy-3-[(1-hydroxy-3-{10-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO7 (441.17874320000004)
(9s,12r)-12-(acetyloxy)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-yl acetate
C24H27NO7 (441.17874320000004)
(2e,6e)-8-(4,6-dihydroxy-2-{[5-(hydroxymethyl)furan-2-yl]methyl}-1-oxo-3h-isoindol-5-yl)-2,6-dimethylocta-2,6-dienoic acid
C24H27NO7 (441.17874320000004)
2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,6s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO7 (441.17874320000004)
3-({3-[(1s,5s,6r,7s,9s,10s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-1-hydroxypropylidene}amino)-2,4-dihydroxybenzoic acid
C24H27NO7 (441.17874320000004)
(2e)-n-[(2r,4e)-2-(3,4-dimethoxyphenyl)-3-oxo-5-phenylpent-4-en-1-yl]-3-phenylprop-2-enimidic acid
C28H27NO4 (441.19399820000007)
n-[(2r,3s,4as,8r,8ar)-8-chloro-2,4a-dihydroxy-8a-methyl-5-oxo-2,3,4,8-tetrahydro-1-benzopyran-3-yl]-12-hydroxydodeca-2,10-dienimidic acid
C22H32ClNO6 (441.19180420000004)
2-({2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-3-phenylpropanoic acid
(1r,21s,22s,23r)-22-hydroxy-11,23-dimethyl-21-propyl-24-oxa-20-azahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁸,¹³]pentacosa-2,4,7(16),8,10,12,14,18-octaene-6,17-dione
C28H27NO4 (441.19399820000007)
2-{4-[(3,5-dihydroxy-6-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]phenyl}acetonitrile
C20H27NO10 (441.1634882000001)
(1r,4r,5r,8r,9s,19r)-9-ethyl-4,5,9-trihydroxy-4-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C21H31NO9 (441.19987160000005)
(21s,22s,23r)-22-hydroxy-11,23-dimethyl-21-propyl-24-oxa-20-azahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁸,¹³]pentacosa-2,4,7(16),8,10,12,14,18-octaene-6,17-dione
C28H27NO4 (441.19399820000007)
(1s,13s,15r,18r)-15-{[(3s)-3-hydroxybutanoyl]oxy}-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-yl (2e)-but-2-enoate
C24H27NO7 (441.17874320000004)
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,6r,8s,10s)-10-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO7 (441.17874320000004)
(e,2z,4z)-n-[(1e)-3-{7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.0³,⁸]heptadeca-3,5,7-trien-11-yl}prop-1-en-1-yl]hepta-2,4-dienimidic acid
2-amino-6-hydroxy-7-methyl-5-(2-{4,8,9-trimethyl-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-3-yl}propanoyl)naphthalene-1,4-dione
C24H27NO7 (441.17874320000004)
(5r,12s,13r,16r)-12-hydroxy-5-methyl-4,6-dioxo-15-[(1e,3e)-penta-1,3-dien-1-yl]-14-oxa-9-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,7-trien-5-yl (3s)-3-hydroxybutanoate
C24H27NO7 (441.17874320000004)
(2s)-2-phenyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile
C20H27NO10 (441.1634882000001)
(e,2z,4z)-n-[(1e)-3-[(1s,11s,13r,15r)-7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.0³,⁸]heptadeca-3,5,7-trien-11-yl]prop-1-en-1-yl]hepta-2,4-dienimidic acid
2-amino-6-hydroxy-5-[(2e,4r)-4-[(2s,3r,4r,5s)-4-hydroxy-3,5-dimethyl-6-oxooxan-2-yl]-2-methylpent-2-enoyl]-7-methylnaphthalene-1,4-dione
C24H27NO7 (441.17874320000004)
(4s,6r,7r,11z)-4-hydroxy-4-[(1s)-1-hydroxyethyl]-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C21H31NO9 (441.19987160000005)
(4r,7r)-n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid; maleic acid
C23H27N3O6 (441.18997620000005)
(6r)-3,4-bis(4-hydroxyphenyl)-6-(2-methylpropyl)-7-oxa-2-azatricyclo[7.4.0.0²,⁶]trideca-1(13),3,9,11-tetraene-5,8-dione
C27H23NO5 (441.15761480000003)
5-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-4,6,7,8-tetrahydroxy-2-oxooctanoic acid
(1r,4r,5s,8r,9s,19r)-9-ethyl-4,5,9-trihydroxy-4-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C21H31NO9 (441.19987160000005)
2-amino-6-hydroxy-5-[4-(4-hydroxy-3,5-dimethyl-6-oxooxan-2-yl)-2-methylpent-2-enoyl]-7-methylnaphthalene-1,4-dione
C24H27NO7 (441.17874320000004)